COMPASS Pathways PLC ADR (CMPS): Price and Financial Metrics Recent IPO


COMPASS Pathways PLC ADR (CMPS) Recent IPO

Today's Latest Price: $37.30 USD

1.57 (4.39%)

Updated Nov 24 4:00pm

Add CMPS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

CMPS Stock Price Chart Interactive Chart >

Price chart for CMPS

CMPS Price/Volume Stats

Current price $37.30 52-week high $47.29
Prev. close $35.73 52-week low $22.51
Day low $35.10 Volume 385,500
Day high $37.99 Avg. volume 625,628
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap 1.30B

COMPASS Pathways PLC ADR (CMPS) Company Bio


COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.


CMPS Latest News Stream


Event/Time News Detail
Loading, please wait...

CMPS Latest Social Stream


Loading social stream, please wait...

View Full CMPS Social Stream

Latest CMPS News From Around the Web

Below are the latest news stories about COMPASS Pathways plc that investors may wish to consider to help them evaluate CMPS as an investment opportunity.

COMPASS Pathways prices upsized IPO above range at $17

Mental health care company, COMPASS Pathways (CMPS) has priced its upsized IPO in the U.S. of 7.5M (6.7M) American Depositary Shares (ADSs) representing 7.5M ordinary shares at $17.00/ADS, higher than previous range of $14-$16, for total gross proceeds of $127.5M.Trading kicks off September 18.Underwriters' over-allotment is an additional 1.125M ADSs.Closing date...

Seeking Alpha | September 18, 2020

COMPASS Pathways surpasses IPO price by 37.6%

Psychedelic biotech, COMPASS Pathways (CMPS) opens at $23.4, above IPO price of $17.The expected range of the IPO was $14-$16.Previously: COMPASS Pathways hints to open at $25 vs. IPO price of $17 (Sept. 18)...

Seeking Alpha | September 18, 2020

Read More 'CMPS' Stories Here

CMPS Price Returns

1-mo 4.48%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6962 seconds.